Clinical Trials Directory

Trials / Completed

CompletedNCT04469348

Inflammation, Intracellular Invasion and Colonization of the Nasal Mucosa by Staphylococcus Aureus

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
157 (actual)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

An inflammatory state of the nasal cells (very close to keratinocytes) could favour the internalization of Staphylococcus aureus and thus constitute a persistent reservoir for the carriage of this bacterium. Staphylococcus aureus is a commensal bacterium of the skin and mucous membranes that colonizes approximately 2 billion people worldwide Staphylococcus aureus is also a leading cause of community and healthcare-associated infection. Staphylococcus aureus has demonstrated its ability to invade many non-professional phagocytic cell lines such as keratinocytes, osteoblasts, fibroblasts, epithelial cells and endothelial cells. During pro-inflammatory stimulation, internalization of Staphylococcus aureus into keratinocytes is mainly mediated by ICAM-1. These results suggest that, in humans, an inflammatory state of the nasal cells (very close to keratinocytes) could promote the internalization of Staphylococcus aureus and thus constitute a persistent reservoir for the carriage of this bacterium.

Detailed description

The main objective is to compare the expression level of ICAM-1 in nasal cells with and without the presence of Staphylococcus aureus.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTnasal swabnasal swab will be performed to analysis biological markers at every visit.

Timeline

Start date
2021-10-18
Primary completion
2023-01-09
Completion
2023-01-09
First posted
2020-07-14
Last updated
2024-05-23

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04469348. Inclusion in this directory is not an endorsement.